Skip to main content

Anti-acne effects of Castanea crenata bur extract and identification of active compound

Abstract

Acne vulgaris is a common disease of the pilosebaceous unit. Hyperseborrhea, a follicular colonization by Cutibacterium acnes and a complex inflammatory state are pathogenic factors of acne vulgaris. In the present study we investigated the anti-acne efficacy of Castanea crenata bur extract (CBE) in vitro and searched active compound for mitigating hyperseborrhea. In sebocytes, CBE inhibited the sebum synthesis through downregulation of sterol response element-binding protein-1 and peroxisome proliferator-activated receptor γ expression. CBE also inhibited the 5-alpha reductase activity which is associated with androgen-induced sebum production. Moreover, CBE showed anti-inflammatory effect in C. acnes and free fatty acid-induced inflammatory condition through suppressing Toll-like receptor 2 activity. Anti-inflammatory effect was also observed in keratinocytes via inhibition of NF-κB translocation into nuclei. Finally, we identified the ellagic acid as an active compound for inhibiting sebum production in CBE. These findings suggest that CBE have potential to be a multi-target agent for acne vulgaris and a good source of ellagic acid as an anti-sebum compound.

Introduction

Acne vulgaris is a chronic inflammatory skin disease related to the pilosebaceous unit. In acne lesions, hyperseborrhea, dysseborrhea, elevated dihydrotestosterone (DHT) levels, abnormal follicular keratinization responsible for the comedone formation, an imbalance in skin microflora, particularly an increase of Cutibacterium acnes (C. acnes) colonization, and an inflammation have been observed [1].

Sebum is produced by sebocytes which constitute a major part of the sebaceous glands (SGs). Sebocytes start proliferation at the junctional zone of SGs and hair follicles (HFs) and differentiation begin after migration to the maturation zone of the SGs. Fully differentiated sebocytes secrete sebum through a lysis process, which called a holocrine secretion. Sebum production is affected by steroid hormones, vitamin A derivatives, insulin-like growth factor 1 (IGF-1), and free fatty acids (FFAs). Sterol response element-binding protein-1 (SREBP-1) and peroxisome proliferator-activated receptors (PPARs) are key transcriptional regulators of lipid synthesis in sebocytes [2].

Sebum is a mixture of lipids mainly composed of triglyceride (TG) and FFAs [3]. TG is hydrolyzed into FFAs by bacteria, especially C. acnes, as well as genuine FFAs secreted from sebocytes. Excessive sebum production is a major event in puberty acne, which contributes to comedone formation, sebogenesis, and inflammation [4]. Palmitic acid (PA), saturated fatty acid, is recently discovered to play an important role in upregulation of lipid contents and inflammatory response of the skin [5].

Higher androgen level is known to contribute to acne vulgaris through activation of sebum production. Testosterone, the major sex hormone in men, is converted to DHT by 5α-reductase. DHT is an agonist of the androgen receptor (AR) with about two-to four-fold higher affinity than testosterone. Binding with AR in the cytoplasm lead to translocate AR into the nucleus and then subsequently activates the lipid metabolism related gene expression. Thus, the downregulation of 5α-reductase has been considered as a target for acne vulgaris by inhibiting excessive sebum production [6].

During acne lesion development, inflammation is observed at most stages. C. acnes is one of the major bacteria responsible for acne and plays a critical role in induction and maintenances of inflammation. In keratinocytes, C. acnes is reported to activate inflammation through Toll-like receptor 2 (TLR2) and nuclear factor kappa-light-chain-enhancer of activated B (NF-κB) pathways [7]. Along with the inhibition of sebum production in sebocytes, the downregulation of inflammation induced by C. acnes is an additional therapeutic alternative to remedy and prevents acne vulgaris.

Castanea crenata Siebold and Zucc (C. crenata) is classified in the Fagaceae family and inhabits northeast asian countries including Korea and Japan. The extracts from various parts of this species have been reported to exert antioxidant, antimicrobial, and anti-allergic activities [8]. C. crenata bark contains tannin used as preservatives, the outer and inner shells of C. crenata have anti-adipogenic activity, and other parts like leaves, flowers, and the inner skin abound with phenolic and flavonoid compounds with antioxidant properties [9]. C. crenata bur (chestnut bur), also known as involucre, is a waste product of chestnuts and has been used as traditional medicine for erysipelas, pertussis, and bronchitis. The anti-viral activity of the flavonoid glycoside derived from chestnut bur was reported by Kim et al. [10], but the effects on the skin have not been elucidated yet. In this study, we investigated the anti-acne properties of C. crenata bur extract on the three well described acne triggers: hyperseborrhea (sebum production), androgenic hormone level (5α-reductase activity), and inflammation induced by C. acnes and FFAs, and then elucidated the active compound for inhibiting sebum synthesis.

Materials and methods

Preparation of C. crenata bur extract

Dried C. crenata bur purchased from the Pungcheon Ginseng Medicinal Herbs Farming union (Korea, 33 g) was extracted with distilled water (320 mL) for 3 h at 100 ℃ and filtered. The extract was concentrated in a rotary evaporator at 55 ℃ and dried using a freeze dryer at 50 ℃ for 24 h. The yield of C. crenata bur extract is 2.8%. The extract dissolved in distilled water was named C. crenata bur extract (CBE) and used in all experiments.

Sebocytes culture and Nile red staining for lipid synthesis

Human sebocytes purchased from Celprogen (Torrance, CA, USA) were cultured in Human Sebocyte Complete Growth Media (Celprogen) at 37 °C in a 5% CO2 incubator. Human sebocytes were differentiated with 100 μM palmitic acid (Sigma-Aldrich, St. Louis, MO, USA) with or without CBE or ellagic acid for 48 h. The treated cells were washed using 1 × PBS and fixed with 4% formaldehyde for 10 min at room temperature (RT). After washing three times, the cells were stained with 10 μg/mL Nile red (Sigma-Aldrich) diluted in 1 × PBS at a 1:100 ratio for 15 min at RT. The nuclei were stained with Hoechst 33342 (Thermo Fisher Scientific, Waltham, MA, USA) solution and fluorescence was detected at excitation and emission wavelengths of 550 nm and 630 nm, respectively.

Triglyceride (TG) ELISA assay

TG released from sebocytes were measured by using ELISA (Triglyceride Quantification Assay Kit, Abcam, Cambridge, UK) according to the manufacturer’s instructions. The reaction mixture was added and shaken for 60 min at RT protected from light and the absorbance was measured at 570 nm using a spectrophotometer (BioTek, Winooski, VT, USA).

Western blot analysis of SREBP-1 and PPARγ

For western blot analysis of SREBP-1 and PPARγ, the sebocytes were seeded into a 60 mm dish and incubated in Dulbecco’s modified Eagle’s medium (DMEM, Hyclone, Logan, UT, USA) containing 1% serum and treated with CBE at 1, 10 and 50 µg/mL at 37 °C for 3 days. Cells were collected from the dishes and lysed with lysis buffer (PRO-PREP, iNtRON Biotechnology, Seongnam, Korea). After sonication, the cell lysate was centrifuged at 16,200×g for 10 min and the pellet was removed. Proteins were quantified by the Bradford assay and separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). The proteins were transferred to nitrocellulose membranes using a transfer kit (iBlot2, iBlot gel transfer stacks, Thermo Fisher Scientific) and blocked with 5% skim milk solubilized in 1 × PBS containing 0.1% Tween 20 (PBST, Sigma-Aldrich) at RT for 1 h. Then, the membranes were incubated with PPARγ antibody (1:1000) (Cell Signaling Technology, Danvers, MA, USA), SREBP1 antibody (1:1000) (Novus Biologicals, Centennial, CO, USA), and GAPDH (1:1000) (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at 4 ℃ overnight. After washing with PBST three times, the membrane was incubated with mouse or rabbit IgG secondary antibody (1:1000, Cell Signaling Technology) at RT for 1 h and the reaction was developed with chemiluminescence substrate (GloBrite ECL Reagent Kit, R&D System, Detroit, MI, USA). The detected proteins were normalized to the individual non-phosphorylated form or GAPDH.

5α-reductase activity assay

Active solution (0.5 mL) was prepared with or without a CBE in 1 mmol/L dithiothreitol (Thermo Fisher Scientific), pH 6.5, 40 mmol/L potassium phosphate (Sigma-Aldrich), 100 μmol/L NADPH (Roche Holding AG, IN, USA), and 3.5 μmol/L testosterone (ChemFaces, Hubei, China) for 20 min at RT. Then, 20 μg of rat liver microsomes (Sigma-Aldrich) was added and incubated for 30 min at 37 ℃ to start the reaction. After lyophilizing the reaction solution, it was dissolved in methanol and filtered through a 0.2-micron filter (Pall, NY, USA). Finally, testosterone was measured by HPLC (Waters 2695 Separation Module, Waters 2996 Photodiode Array Detector, Waters, MA, USA) on a C18 column (4.6 × 150 mm, 2.6 μm, Phenomenex, Torrance, CA, USA) at RT, and a UV detection wavelength of 245 nm. The analysis was conducted with an isocratic mobile phase of 0.1% trifluoroacetic acid in water: acetonitrile (50:50, v/v) at a flow rate of 1.0 mL/min.

Preparation of the conditioned medium of C. acnes

The strain of C. acnes ATCC 6919 used in this study was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). C. acnes was anaerobically cultured in Reinforced Clostridial Medium (RCM, Difco, Franklin Lakes, NJ, USA) at 37 ℃ for 48 h. C. acnes was cultured in a 96-well microplate with or without CBE, respectively. C. acnes was adjusted to 1 × 107 colony-forming units (CFU)/mL in RCM. CBE was dissolved in distilled water and prepared in media at concentrations of 10, 50, 100, 500, 1000, and 2000 μg/mL. Each well was inoculated with 1 × 105 CFU/mL of the bacterial suspension and the microplate was incubated for 18 h. After collecting the conditioned medium, the supernatant was filtrated through a 0.22-micron pore-sized filter (EMD Millipore, Temecula, CA, USA) and treated with 1/100 dilution in cells. The conditioned medium recovered by culturing C. acnes was named C. acnes CM, and the conditioned medium with CBE was named C. acnes CBE, respectively (Fig. 1A, B).

Fig. 1
figure 1

Schematic of the preparation of the cultured medium of C. acnes. A C. acnes CM. B C. acnes CBE

TLR2/NF-κB/SEAP activity assay

HEK293-hTLR2 cells (HEK293-Blue™ hTLR2, InvivoGen, San Diego, CA, USA) was used to determine the effect of CBE on TLR2. The TLR2 reporter cell line is a stably co-transfected cell line which expresses full-length human TLR2 and the secreted alkaline phosphatase (SEAP) reporter gene under the transcriptional control of an NF-κB response element. HEK293-hTLR2 cells were cultured in DMEM with 4 mM L-glutamine, 4500 mg/L glucose, and sodium pyruvate supplemented with 10% fetal bovine serum (FBS, Gibco) at 37 °C in a 5% CO2 incubator. HEK293-hTLR2 cells were seeded in 48-well plates and cultured in serum-free DMEM with C. acnes CM or C. acnes CBE. After 6 h, cultured medium was collected and reacted with QUANTI-Blue™ solution (InvivoGen), then incubated at 37 ℃ in a 5% CO2 incubator for 30 min. SEAP activity was measured by reading the optical density (OD) at 620 nm with a microplate reader.

Immunocytochemistry assay of NF-κB p65 nuclear translocation

NF-κB p65 nuclear translocation was detected to confirm inflammatory process activation in the human epidermal keratinocytes (HEKn). HEKn (ATCC, Manassas, VA, USA) were cultured in EpiLife™ Medium with 60 µM calcium (Gibco, Carlsbad, CA, USA) and Human Keratinocyte Growth Supplement (HKGS, Gibco) with CBE and C. acnes CM at 37 ℃ in a 5% CO2 incubator for 1 h. After washing with PBS, the cells were fixed with 4% formaldehyde (Sigma-Aldrich), washed using PBS three times, and permeabilized with 0.2% Triton X-100 (BIOSESANG, Seongnam, Korea). Then cells were washed three times and blocked with 5% albumin (Albumin Fraction V, bioWORLD, Dublin, OH, USA) in PBS. The cells were treated with NF-κB p65 polyclonal antibody (1:200) (eBioscience™, Thermo Fisher Scientific) overnight at 4 ℃, then with rabbit IgG antibody tagged with Alexa Fluor 488 (1:200) (Merck, Darmstadt, Germany). The nuclei were stained with Hoechst 33342 (Thermo Fisher Scientific) before detecting NF-κB p65 translocation using a fluorescence microscope (EVOS® FL, Thermo Fisher Scientific).

Western blot analysis of phospho-IκBα and IκB

For western blot analysis of phospho-IκBα and IκBα, the HEKn were seeded into a 60 mm dish and incubated in DMEM containing 1% FBS and treated with CBE at 1, 10 and 50 µg/mL and C. acnes CM at 37 °C for 3 days. Then, follow the same steps as above. The membranes were incubated with phospho-IκBα (Ser32) antibody (1:1000), IκBα antibody (1:1000) (Cell Signaling Technology), at 4 ℃ overnight.

Activity guided identification of active compound

C. crenata bur was extracted with boiling water in a reflux system. The aqueous extract (10.15%) was suspended in EtOH (70%, v/v), then the soluble part was evaporated and partitioned by chloroform, ethyl acetate, and n-butanol, depending upon the solvent polarity. Thus, the ethyl acetate fraction was further separated by methanol precipitation. After precipitation, the soluble part was separated using silica gel and Sephadex LH-20 column chromatography, and the precipitated fraction was dissolved in dimethyl sulfoxide (DMSO). Figure 6A shows the schematic of the fractionation of CBE.

The HPLC system used in this study was a Waters 2695 (Waters, Milford, MA, USA) system equipped with a Waters 996 Photodiode Array (PDA) Detector. Empower 2 software was used to control the analytical system and perform the data collection and processing. HPLC–PDA analysis was performed on a Phenomenex Luna C18 (2) (4.6 × 150 mm, 5 μm) reverse-phase column protected by a C18 guard column from Phenomenex, Inc. (Torrance, CA, USA). The sample injection volume was 10 μL. The signal was monitored at 240 nm. The elution system used for the HPLC–PDA assay was a binary high-pressure gradient elution system with mobile phase A (0.1% trifluoroacetic acid (TFA) in H2O) and mobile phase B (acetonitrile). The elution gradient was 10% organic phase B, held for 7 min; then, 10–55% organic phase B in 21 min (linear gradient); 55–70% organic phase B in 4 min (linear gradient); then return to the starting condition in 3 min and re-equilibration for 5 min. The flow rate was 1.0 mL/min. Each analysis required 40 min, including the re-equilibration time.

Statistical analysis

All experiments were conducted at least three times, and the data are expressed as the mean  ±  standard deviation (SD). The data were analyzed by the student’s t test. A P value less than 0.05 was considered statistically significant.

Results

Effect of CBE on sebum synthesis of sebocytes

Excessive sebum production known as hyperseborrhea is the major causative step of acne vulgaris. To confirm the inhibitory effect of CBE on sebum synthesis, we used a PA-induced differentiation model of sebocytes. PA has been reported to associated with sebum synthesis and inflammation in acne [3]. As shown in Fig. 2A, CBE significantly inhibited the PA-induced sebum production at a concentration of 10 and 50 μg/mL. Since TG is a major component of sebum, we also quantified the secreted TG levels by using ELISA. As expected, CBE decreased the level of TG in a dose dependent manner (Fig. 2B). Then, to explore the regulatory mechanism of CBE on lipid synthesis, we assessed the expression level of SREBP-1 and PPARγ, which are well-known transcriptional factors of lipid synthesis. As a result, we found that CBE decreased the expression levels of SREBP-1 and PPARγ induced by PA (Fig. 2C). These results suggest that CBE inhibited the PA-induced sebum production by downregulation of SREBP-1 and PPARγ expression in sebocytes.

Fig. 2
figure 2

CBE suppresses sebum production, and TG, SREBP-1 and PPARγ expression induced by PA in sebocytes. A Sebocytes were treated PA with or without retinol or CBE and incubated for 48 h. To detect sebum synthesized in the sebocytes, Nile red staining was performed, and sebum droplets were observed by fluorescence microscopy. Scale bar is 100 µm. The fluorescence intensity of the droplets was calculated using ImageJ. B Sebocytes were cultured and incubated for 72 h with or without CBE. TG levels were measured using the TG ELISA Kit. C Prepared sebocytes lysates were treated. Protein levels of SREBP-1, PPARγ and GAPDH were detected. The levels of SREBP-1 and PPARγ were normalized to that of GAPDH (n  = 3). These data are presented as the mean  ±  SD, *P  < 0.05 compared to PA-treated control

Effect of CBE on 5α-reductase activity

Androgen-induced sebum production is considerably related to 5α-reductase enzyme activity, which converts testosterone to DHT. DHT, the active androgenic form of testosterone, has a higher affinity for the AR than testosterone. Therefore, the inhibition of 5α-reductase can play a critical role in improving DHT-mediated acne through decreasing sebum synthesis. To explore the inhibitory effect of CBE on 5α-reductase activity, we measured the remaining testosterone in an enzymatic reaction using testosterone and rat liver microsomes containing 5α-reductase. The higher amount of testosterone in reaction mixture means that the activity of 5α-reductase is inhibited. As shown in Fig. 3, CBE inhibited the conversion of testosterone to DHT in a dose dependent manner. Finasteride, used as a positive control, also showed inhibitory effect on 5α-reductase. The result suggests that CBE can be effective to mitigate acne vulgaris by inhibition of 5α-reductase activity.

Fig. 3
figure 3

CBE inhibits 5α-reductase activity. The liver microsomal fraction containing 5α-reductase activity was put in contact to finasteride or CBE. After lyophilizing the reaction solution, the remaining testosterone was analyzed by HPLC (n  = 3). The data are presented as the mean  ±  SD, *P  < 0.05 compared to 5α-reductase-treated control

Effect of CBE on C. acnes and FFA-induced TLR2 activation in HEK293-hTLR2 cells

TLR2 ligands present on C. acnes have been known to initiate inflammatory gene expression and contribute to the vicious inflammatory circle of acne. To explore the anti-inflammatory effect of CBE on TRL2 activity, we used the HEK293-hTLR2 cells in C. acnes and FFAs induced inflammation model. We first check whether CBE can inhibit the level of virulence factors secreted from C. acnes, we used the C. acnes CM and C. acnes CBE. We applied the collected C. acnes CM and C. acnes CBE to HEK293-hTLR2 cells for 6 h and then measured the TLR2 activity. As a result, we observed that C. acnes CBE significantly decreased the TLR2 activity compared to C. acnes CM (Fig. 4A). Then we found that CBE can attenuate the C. acnes CM induced inflammation in HEK293-hTLR2 cells. As shown in Fig. 4B, CBE inhibited the C. acnes CM-induced TLR2 activation in a dose dependent manner. These results suggest that CBE can exert anti-inflammatory effect by inhibiting the secretion of virulence factors from C. acnes as well as direct action on C. acnes-induced inflammatory pathway.

Fig. 4
figure 4

CBE inhibits TLR2-mediated inflammatory pathway induced by C. acnes and PA in HEK293-TLR2 cells. A The HEK293-TLR2 cells were cultured in serum-free conditions and treated with C. acnes CM or C. acnes CBE. B The HEK293-TLR2 cells were cultured in serum-free conditions, treated with C. acnes CM, and CBE were added for 6 h. C The HEK293-TLR2 cells were cultured in serum-free conditions and PA was treated with or without CBE for 18 h. TLR2 activity was measured through the secreted alkaline phosphatase. The values are expressed compared to the control, which was considered to be 100% (n  = 3). The data are presented as the mean  ± SD, *P  < 0.05 compared to the control group

PA, a FFA well-known to trigger inflammation in acne vulgaris, induces activation of TLR2 pathway and secreting IL-1β related to inflammasome [5, 11]. We found that PA stimulates the TLR2 signaling pathway and this activation was effectively reduced by CBE (Fig. 4C). The result indicates that CBE can be also effective in inflammatory acne vulgaris lesions by preventing the inflammatory responses induced by PA. Therefore, it is expected that CBE can be effectively applied for relieving inflammation occurring in inflammatory acne vulgaris lesions.

Effect of CBE on C. acnes-induced NF-κB activation in epidermal keratinocytes

Keratinocytes are important in the innate immune activation of inflammatory acne lesions on the skin. To investigate whether CBE exert anti-inflammatory activity against C. acnes on HEKn, we performed an immunocytochemistry for NF-κB p65 translocation and western blot analysis for IκBα expression. As shown in Fig. 5A, upon treatment with C. acnes CM, the nuclear translocation of NF-κB p65 was increased in keratinocytes, while treatment with CBE mitigated the C. acnes CM-induced NF-κB p65 translocation. NF-κB p65 translocation is related to IκBα, which binds to NF-κB and prohibits the translocation of NF-κB to the nucleus. Once IκBα is phosphorylated by IKK, IκBα is degraded and the translocation of NF-κB p65 occurs. Therefore, we analyzed the expression of phosphorylated IκBα in HEKn. In Fig. 5B, C. acnes CM increased the phosphorylation of IκBα, which was inhibited by CBE in a dose dependent manner. These data suggest that CBE suppress C. acnes-induced inflammation by inhibiting NF-κB pathway in HEKn.

Fig. 5
figure 5

CBE decreased C. acnes CM-induced NF-κB p65 translocation and IκBα phosphorylation in HEKn. A Immunofluorescence of NF-κB p65 subunit translocation in HEKn cultured in C. acnes CM or C. acnes CBE. The blue and green fluorescence indicates the nucleus and NF-κB p65 subunit, respectively. B After cell lysis, phosphorylated IκBα, IκBα, and GAPDH protein expression were detected by western blots. The protein levels were normalized to that of GAPDH, n  = 3

Identification of ellagic acid as an active compound in CBE

To elucidate the active compound of CBE responsible for sebum production, we performed a bioassay-guided fractionation (Fig. 6A). Among the fraction obtained, we found that the ethyl acetate fraction most effectively inhibits sebum production (Additional file 1: Figure S1). The inhibitory activity on sebum production was found in the precipitate (Additional file 1: Figure S2), and the main active compound was determined to be ellagic acid using HPLC analysis (Fig. 6B). The content of ellagic acid was 1.1% in the aqueous extract, but it reached 64% in the fraction R10. To examine the effect of ellagic acid on sebocytes differentiation, sebocytes were treated with various concentrations (1, 10, and 50 μg/mL) of ellagic acid, and the level of lipid synthesis was analyzed by Nile red staining. Figure 7 shows that ellagic acid decreases the fluorescence intensity by 76%, 52%, and 36% at 1, 10, and 50 μg/mL, respectively, compared to the PA-treated control. These results demonstrate that ellagic acid is an active compound of CBE that inhibits the sebum accumulation induced by PA in sebocytes.

Fig. 6
figure 6

CBE was fractionated and analyzed by HPLC. A Schematic of the fractionation of CBE. B Ellagic acid peak in the fraction R10 (lower) and in the ellagic acid standard (upper)

Fig. 7
figure 7

Ellagic acid suppressed sebum production induced by PA in sebocytes. Sebocytes treated PA with or without ellagic acid and incubated for 48 h. Sebum accumulation was detected by Nile red staining and sebum droplets were observed by fluorescence microscopy. Scale bar is 100 µm. The fluorescence intensity of the droplets was measured using ImageJ (n  = 3). The data are presented as the mean  ±  SD, *P  < 0.05 compared to the control group

Discussion

Various pharmacological treatments have been considered as anti-acne therapies. Among them, retinoids have been widely used for a long time. Retinoids exert anti-acne efficacy through inhibition of C. acnes-induced cytokine secretion by reducing TLR2 pathway and downregulation of sebum production [12, 13]. Despite significant efficacy of retinoids on acne therapies, several adverse effects such as pruritus, erythema, peeling, burning sensation, cheilitis, xerosis, and local irritation has been consistently reported [14]. For this reason, it is very meaningful to develop safe anti-acne agents derived from natural materials that can replace retinoids. In this study, we demonstrated that CBE reduces lipid accumulation by decreasing the expression of SREBP-1 and PPARγ, a regulator of fatty acid synthesis in sebocytes. And it was confirmed that EA from CBE was an active ingredient with an inhibitory effect on sebum synthesis. CBE also inhibited 5α-reductase activity and suppressed the TLR-mediated inflammatory response leading to the activation of NF-κB induced by C. acnes and FFA. In addition, CBE downregulates the NF-κB translocation and IκBα phosphorylation induced by C. acnes. Therefore, it is expected that CBE will have the ability to reduce comedolytic activity by reducing the NF-κB pathway in keratinocytes.

C. acnes is found in sebaceous glands producing sebum, which is used as the primary energy source of C. acnes. C. acnes-induced inflammation is an important step in various types of acne lesions by activating TLRs on keratinocytes and macrophages [15]. C. acnes secretes inflammatory factors called virulent molecules or factors like co-hemolytic Christie-Atkins-Munch-Peterson (CAMP) factors, lipase, sialidases, hyaluronate lyase (HYL), and porphyrins, which are recognized by pattern recognition receptors. TLR2 recognizes pathogen-associated molecular patterns (PAMPs) secreted from C. acnes and activates NF-κB signalling, stimulating the transcription of pro-inflammatory cytokines in the nucleus [16]. Therefore, virulence factors are considered as major triggers of inflammation in acne. In this study, we indirectly observed the effect of CBE on the secretion of virulence factors from C. acnes by measuring TLR2 activity in C. acnes induced inflammation model. CBE inhibited TLR2 activity by inhibiting the secretion of virulence factors from C. acnes (Fig. 4A). Since CBE did not show any antimicrobial activity against C. acnes (Data not shown), the effect of CBE on TLR2 activation may derived from the reduction of virulence factors secretion from C. acnes. Moreover, CBE directly inhibited the TLR2 activity induced by C. acnes CM (Fig. 4B).

In the epidermis, the keratinocytes inflammation through the activation of TLR2 is considered to have an important role in comedogenesis. PAMPs-induced TLR2 activation through NF-κB pathway stimulates normal human epidermal keratinocytes to release IL-1α, which promotes hypercornification like the TLR agonist-treated effect in isolated sebaceous glands [7]. Therefore, downregulating NF-κB activation in keratinocytes may contribute to reducing comedogenesis. In this study, we confirmed that CBE decreased C. acnes CM-induced inflammation by inhibiting IκBα phosphorylation, which subsequently inhibits NF-κB p65 translocation to nuclei in HEKn (Fig. 5). Therefore, CBE could reduce comedogenesis related to inflammation in acne vulgaris lesions by reducing TLR2 signaling through the NF-κB pathway.

Ellagic acid is a heterocyclic compound usually found in fruits and nuts of plant and has been reported to show anti-inflammatory, antioxidant, antiviral, anticancer and anti-adipogenic activity [17, 18]. For example, ellagic acid reduces pro-inflammatory factors like TNF-α, IL-6, and IL-1β in the sera of rats and recovers D-galactose-reduced antioxidant activity by upregulating superoxide dismutase, catalase, and glutathione peroxidase. It can also regulate cholesterol metabolism by suppressing SREBP-2 in rat livers as a bioactive compound of unripe Rubuscoreanus [19]. Recently, ellagic acid was shown to alleviate UVB-induced skin wrinkles by reducing phototoxicity and preventing collagen degradation [20]. However, its effects on acne have not yet been elucidated. In this study, we found that ellagic acid inhibits sebum accumulation in sebocytes. Further study is needed to confirm the efficacy of ellagic acid on the other target of acne and regulatory mechanism of sebum synthesis.

References

  1. Cong TX, Hao D, Wen X, Li XH, He G, Jiang X (2019) From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res 311(5):337–349

    CAS  Article  Google Scholar 

  2. Clayton RW, Göbel K, Niessen CM, Paus R, Steensel MAM, Lim X (2019) Homeostasis of the sebaceous gland and mechanisms of acne pathogenesis. Br J Dermatol 181(4):677–690

    CAS  Article  Google Scholar 

  3. Lovászi M, Szegedi A, Zouboulis CC, Törőcsik D (2017) Sebaceous-immunobiology is orchestrated by sebum lipids. Dermato-Endocrinol 9(1):e1375636

    Article  Google Scholar 

  4. Bergler-Czop B, Brzezińska-Wcisło L (2013) Dermatological problems of the puberty. Postepy Dermatol Alergol 30(3):178–187

    Article  Google Scholar 

  5. Choi CW, Kim Y, Kim JE, Seo EY, Zouboulis CC, Kang JS, Youn SW, Chung JH (2019) Enhancement of lipid content and inflammatory cytokine secretion in SZ95 sebocytes by palmitic acid suggests a potential link between free fatty acids and acne aggravation. Exp Dermatol 28(2):207–210

    CAS  Article  Google Scholar 

  6. Lai JJ, Chang P, Lai KP, Chen L, Chang C (2012) The role of androgen and androgen receptor in skin-related disorders. Arch Dermatol Res 304(7):499–510

    CAS  Article  Google Scholar 

  7. Selway JL, Kurczab T, Kealey T, Langlands K (2013) Toll-like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne. BMC Dermatol 13:10

    Article  Google Scholar 

  8. Han SH, Hur MS, Kim MJ, Jung WH, Park M, Kim JH, Shin HJ, Choe YB, Ahn KJ, Lee YW (2017) In vitro anti-Malassezia activity of Castanea crenata shell and oil-soluble Glycyrrhiza extracts. Ann Dermatol 29(3):321–326

    CAS  Article  Google Scholar 

  9. Youn UY, Shon MS, Kim GN, Katagiri R, Harata K, Ishida Y, Lee SC (2016) Antioxidant and anti-adipogenic activities of chestnut (Castanea crenata) byproducts. Food Sci Biotechnol 25(4):1169–1174

    CAS  Article  Google Scholar 

  10. Kim N, Park S, Nhiem NX, Song JH, Ko HJ, Kim SH (2019) Cycloartane-type triterpenoid derivatives and a flavonoid glycoside from the burs of Castanea crenata. Phytochemistry 158:135–141

    CAS  Article  Google Scholar 

  11. Snodgrass RG, Huang S, Choi IW, Rutledge JC, Hwang DH (2013) Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids. J Immunol 191(8):4337–4347

    CAS  Article  Google Scholar 

  12. Liu PT, Krutzik SR, Kim J, Modlin RL (2005) Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol 174(5):2467–2470

    CAS  Article  Google Scholar 

  13. Zouboulis CC, Korge B, Akamatsu H, Xia LQ, Schiller S, Gollnick H, Orfanos CE (1991) Effects of 13-cis-retinoic acid, all-trans-retinoic acid, and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol 96(5):792–797

    CAS  Article  Google Scholar 

  14. Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G (2006) Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging 1(4):327–348

    CAS  Article  Google Scholar 

  15. Zhang B, Choi YM, Lee J, An IS, Li L, He C, Dong Y, Bae S (2019) Toll-like receptor 2 plays a critical role in pathogenesis of acne vulgaris. Biomed Dermatol 3:4

    Article  Google Scholar 

  16. Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol 5:461

    Article  Google Scholar 

  17. Chen P, Chen F, Zhou B (2018) Antioxidative, anti-inflammatory and anti-apoptotic effects of ellagic acid in liver and brain of rats treated by D-galactose. Sci Rep 8(1):1465

    CAS  Article  Google Scholar 

  18. Wang L, Li L, Ran X, Long M, Zhang M, Tao Y, Luo X, Wang Y, Ma X, Halmurati U, Mao X, Ren J (2013) Ellagic acid reduces adipogenesis through inhibition of differentiation-prevention of the induction of Rb phosphorylation in 3T3-L1 adipocytes. Evid Based Complement Alternat Med 2013:287534

    PubMed  PubMed Central  Google Scholar 

  19. Lee KH, Jeong ES, Jang G, Na JR, Park S, Kang WS, Kim E, Choi H, Kim JS, Kim S (2020) Unripe Rubus coreanus Miquel extract containing ellagic acid regulates AMPK, SREBP-2, HMGCR, and INSIG-1 signaling and cholesterol metabolism in vitro and in vivo. Nutrients 12(3):610

    CAS  Article  Google Scholar 

  20. Bae JY, Choi JS, Kang SW, Lee YJ, Park LJ, Kang YH (2010) Dietary compound ellagic acid alleviates skin wrinkle and inflammation induced by UV-B irradiation. Exp dermatol 19(8):e182-190

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

JY and EJ: designed the experiments; JY: conducted the experiments; KBR, HJ and EC: assisted in experiments; JY and KR: analysis of data; JY, KR and EJ: wrote the manuscript; HC and MF: critical revision of manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Eunsun Jung.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Figure S1. Ethyl acetate fraction suppressed sebum production induced by PA in sebocytes. Sebocytes treated PA with or without fractions, ethyl acetate (R6), n-Butanol (R7) and water (R8) respectively, and incubated for 48 h. Sebum accumulation was detected by Nile red staining and sebum droplets were observed by fluorescence microscopy. Scale bar is 100 µm. The fluorescence intensity of the droplets was measured using ImageJ (n = 3). The data are presented as the mean ± SD, *P < 0.05 compared to PA-untreated control; **P < 0.05 compared to PA-treated control. Figure S2. Precipitate of methanol extraction suppressed sebum production induced by PA in sebocytes. Sebocytes were treated with PA with or without several fractions, precipitate (R10), fraction 1 (R11), fraction 2 (R12), fraction 3 (R13), fraction 4 (R14) and fraction 5 (R15) for 48 h. Sebum accumulation was detected by Nile red staining and sebum droplets were observed by fluorescence microscopy. Scale bar is 100 µm. The fluorescence intensity of the droplets was measured using ImageJ (n = 3). The data are presented as the mean ± SD, *P < 0.05 compared to PA-untreated control; **P < 0.05 compared to PA-treated control. Figure S3. LC-MS/MS spectrum of the fraction R10.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

You, J., Ji, H., Roh, KB. et al. Anti-acne effects of Castanea crenata bur extract and identification of active compound. Appl Biol Chem 65, 12 (2022). https://doi.org/10.1186/s13765-021-00670-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13765-021-00670-x

Keywords

  • Castanea crenata
  • Sebocyte
  • Sebum synthesis
  • Anti-inflammation
  • 5-alpha reductase